HeartBeam, Inc. (BEAT)
NASDAQ: BEAT · Real-Time Price · USD
1.580
-0.080 (-4.82%)
May 21, 2025, 4:00 PM - Market closed
HeartBeam Employees
HeartBeam had 21 employees as of December 31, 2024. The number of employees increased by 6 or 40.00% compared to the previous year.
Employees
21
Change (1Y)
6
Growth (1Y)
40.00%
Revenue / Employee
n/a
Profits / Employee
-$967,905
Market Cap
53.29M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 21 | 6 | 40.00% |
| Dec 31, 2023 | 15 | 0 | - |
| Dec 31, 2022 | 15 | 10 | 200.00% |
| Dec 31, 2021 | 5 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
| AbbVie | 55,000 |
BEAT News
- 8 days ago - HeartBeam, Inc. (BEAT) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 8 days ago - HeartBeam Reports First Quarter 2025 Results - Business Wire
- 16 days ago - HeartBeam Announces Two New U.S. Patents, Powering Forward Its Robust Patent Portfolio - Business Wire
- 17 days ago - HeartBeam Appoints CEO Robert Eno to Board of Directors to Support U.S. Commercialization and Growth - Business Wire
- 20 days ago - HeartBeam to Host First Quarter 2025 Results Conference Call on Tuesday, May 13, 2025 at 4:30 p.m. Eastern Time - Business Wire
- 22 days ago - HeartBeam Successfully Meets Clinical Endpoints in Pivotal Study for its Groundbreaking 12-Lead ECG Synthesis Technology - Business Wire
- 27 days ago - HeartBeam and AccurKardia Announce Strategic Collaboration to Advance Cardiac Monitoring Innovation - Business Wire
- 2 months ago - HeartBeam, Inc. (BEAT) Q4 2024 Earnings Call Transcript - Seeking Alpha